Celldex Therapeutics (CLDX) Ownership - Who owns Celldex Therapeutics?

Industry: @Biotechnology

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

53 Frontage Road

Phone

+1 908 200-7500

Employees

160

Web

https://www.celldex.com

Details

Group

Domestic Stock Funds

Fundamentals

CLDX

Capitalization

2.9B

P/E Ratio

N/A

Risk (Beta)

1.00

Dividend Yield

N/A

Total Cash

802M

Total Cash/Share

12.10

Total Debt

2.39M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.15%

Revenue

8.3M

ROE

N/A

Book Value

814M

P/B Ratio

3.57

Cash Flow

N/A

Earnings

-2.75

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

66K

Current Ratio

29.36

Current Revenue Per Employee

15612.50

Dividends Per Share - Security

N/A

EBITDA

-160.19M

Float

N/A

Float - Current

N/A

Gross Income Margin

100.00

Revenue To Assets

-26.24

Shares Held By Institutions

4.74B

Shares Outstanding - Current

66.3M

Total Liabilities

31.9M

Total Volume MTD

N/A

Value

-1

Gain YTD

9.632

View a ticker or compare two or three

Compare

CLDX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CLDX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CLDX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of immunotherapy technologies for the treatment of cancer and other diseases

Industry Biotechnology